Scroll To Top
Search by Speciality

18th World Conference on Lung Cancer (WCLC)

PACIFICO Yokohama Convention Center | Yokohama, JAPAN
From 100 to 1200 USD
Event Preview
107
Days Left
For the
Event
Title: 18th World Conference on Lung Cancer (WCLC)
Specialty: Radiation Oncology
Dates: From Oct, 15, 2017 to Oct, 18, 2017
Location: Yokohama, JAPAN
Type: Conference
Registration Cost: From 100 to 1200 USD
Event Tools
  • Add to Favorites
  • Notify me by email
  • Claim this event
Add to my Calendar
Oct
Weather Info (monthly averages) Max Temperature: C / F Min Temperature: C / F The above data in our Weather Info table are temperature predictions for the date of the medical event for Yokohama, Japan.
General Info
Event Venue:

PACIFICO Yokohama Convention Center

Yokohama, JAPAN Visit the Venue to read more
Currency:
USD
Accreditation:

-

A conference electronic evaluation form will be emailed to learners after the conference. Participants that wish to receive CME credit will have to complete the online evaluation form in order to receive their CME certificate. CME credits will only be provided for the sessions that learners are scanned in for. The CME certificate will be ready for you to print or save upon completion.

This information is used not only to evaluate the present activity, but also to plan for future programs.

Your opinion is very valuable!

Concerned Audience:
  • Medical_Professionals
  • Medical_students
  • Nurses
Event Overview
Welcome message:

Dear Doctors, Dear Colleagues, Dear Friends,

The 18th World Conference on Lung Cancer of the International Association for the Study of Lung Cancer (IASLC) will take place from October 15 – 18, 2017, in Yokohama, Japan. The science of lung cancer is advancing rapidly, so the IASLC recently decided to hold the World Conferences annually. The IASLC WCLC in Yokohama will be the second of the annual Conferences, following the IASLC World Conference in Vienna, Austria, in 2016.

On behalf of IASLC as well as the members of the Organizing and Program Committees, we would like to cordially invite you to attend the World Conference on Lung Cancer 2017 in Yokohama.

The Conference motto “Synergy to Conquer Lung Cancer” captures the collaborative spirit of the Conference which will be both a scientific and educational event.

Medical doctors, scientists, nurses, health professionals, government officials, partners from the industry, health advocacy groups and patients will come together in order to obtain and exchange information on advances in the management of lung cancer and other thoracic malignancies, while considering both global and regional aspects.

We ask you to submit your latest research results for presentation. You are also welcome to suggest any topic, activity or scientific program you would like to see covered during the World Conference. Your active contribution will be crucial to the success of the World Conference and its impact on our global mission to prevent, diagnose and treat lung cancer and other thoracic malignancies. Together, we will become a stronger voice and global force with the ultimate goal of succeeding in decreasing the world-wide burden of lung cancer.

We hope that, despite an intense Conference program, you also will be able to get some glimpses of Yokohama, Japan. Yokohama is the second largest city in Japan and is a cosmopolitan and modern city, which has played host to many international organizations. Yokohama is also a city rich in history, architecture and culture. 

We look forward to personally welcoming you to Yokohama for the World Conference on Lung Cancer 2017, from all parts of the world.

Yours sincerely,


Dr. Hisao Asamura, MD and Dr. Keunchil Park, MD, PhD

IASLC WCLC 2017 Conference Co-Presidents

Registration Needs updating Register Now
Currency:

USD

Registration Cost
Type
Early Registration

2017-08-04
Late Registration From: 2017-08-05 To: 0--
On site Registration
IASLC member
415
750
950
Non IASLC Member
665
1000
1200
Fellows,Trainee,Student (1999 birth ) Member
150
300
450
Fellows,Trainee,Student (1999 birth ) Non Member
200
350
500
Registered Nurses IASLC Member
150
300
450
Registered Nurses & Allied Health Non Member
200
350
500
Advocate IASLC Member
100
250
350
Advocate Non member
150
300
400

Group Registrations:

Group registrations not allowed

Accompanying Persons:

Accompanying persons not allowed

Registration Documents:
Letter of invitation:
We don’t provide letter of invitation
Letter of confirmation:
We don’t provide Letter of Confirmation
Proof of professional / educational status:
We don’t need Proof of professional/educational status
Online Abstract Submission:

We don’t accept Online Abstracts

Accommodation
Accommodation:
TB Global Marketing & Travel Inc is the official housing bureau for the IASLC 18th World Conference on Lung Cancer and will offer assistance with the coordination of housing requirements for the Conference. Special room rates have been negotiated and will be available to Conference delegates only. Please click the below link and then select the “Entry” button on the corresponding page in order to make an Accommodation Booking at one of our partner hotels for IASLC WCLC 2017 or contact JTB directly on wclc2017_hotel@gmt.jtb.jp or +81-3-5796-5445 to communicate directly with the JTB team


JTB is the official Housing Bureau, however if you have any accommodation queries that JTB has not fully addressed please feel free to contact the official conference organisers International Conference Services (ICS) on wclc2017-Registration@icsevents.com. 

Accommodation Options and Cost

Hotel Name
Type of charge
Single
Room
Double
Room
Distance from Venue
Navios Yokohama
Date range
106
New Otani Inn Yokohama
Date range
176
Breezbay Hotel
Date range
130
Scientific Content Up to Date
Submission Info

The Core Program and Regional Organizing Committee for the IASLC 18th World Conference on Lung Cancer are inviting the submission of scientific abstracts. Authors are asked to submit abstracts under one of the following categories:

Advanced NSCLC

Biology/Pathology

Chemotherapy/Targeted Therapy

Clinical Design, Statistics and Clinical Trials

Early Stage NSCLC

Epidemiology/Primary Prevention/Tobacco Control and Cessation

Immunology and Immunotherapy

Locally Advanced NSCLC

Mesothelioma

Nursing/Palliative Care/Ethics

Patient Advocay

Pulmonology/Endoscropy

Radiology/Staging/Screening

Radiotherapy

SCLC/Neuroendocrine Tumors

Surgery

Thymic Malignancies/Esophageal Cancer/Other Thoracic Malignancies




Abstract submission deadline 2017-06-21
Editorial Guidelines for Abstract Submission

General

Abstracts will be accepted in English only

An international panel of reviewers will review all abstracts anonymously

There is no fee for submitting an abstract

There is no limit to the number of abstracts you may submit (however, an individual may not be offered more than 2 oral presentations)

All Abstracts accepted by the Scientific Committee will be published in the Journal of Thoracic Oncology (JTO) and the Conference website prior to the meeting and it is mandatory to agree to this at the time of submission

Step 1, Title & Topic

The abstract title must not exceed 125 characters in length; this includes spaces

Step 2, Authors

The presenting author of an accepted abstract must be registered by August 18, 2017

There is no limit to the amount of co-authors per abstract

Financial Disclosure information needs to be completed for EACH co-author at the time of submission through the online abstract submission form; however, information can be provided by the submitting author

The submitter can view the status of co-author disclosures by clicking on 'Authors' section of the abstract. Those with incomplete disclosures are denoted in red

If you would like an assistant or other person to receive notifications regarding the status of an abstract, please enter their email address on the text field provided below the list of co-authors

Please note your preferred presentation format. If you would not be comfortable giving an oral presentation, please select Poster Only. NOTE: Selecting Poster/Oral does not guarantee you will be assigned an oral abstract presentation upon acceptance; the final presentation type is determined by the International Scientific Abstract Review Committee

Step 3, Disclosure


ALL abstract authors are expected to disclose to the program audience any/all relevant financial relationships related to the content of their presentation.

IMPORTANT NOTE: Per CME guidelines, industry employees cannot present an abstract if the content of the abstract relates to business lines or products of their employer.

Disclosure of Relevant Financial Relationships:

The author must disclose all entities producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients, with which the author/the author’s spouse/partner have, or have had, a relevant financial relationship within the past 12 months. The ACCME does not consider providers of clinical service directly to patients to be commercial interests.

If the author has a relevant financial relationship, please provide the nature of relevant financial relationship as well as the name of company(s).

Presentation(s) Content: Faculty responsibility:

The author warrants that nothing in their presentation is libelous or will infringe the rights of any third party. The author also warrants that for any third party materials incorporated into their presentation, they have obtained all necessary permission from the copyright owner of such material. Upon request Presenter agrees to furnish copies of said permission(s) to IASLC. The author is responsible for all fees, royalties and other charges for the use of materials. The author shall indemnify IASLC for all damages, costs and expenses, including attorneys’ fees, incurred by IASLC as a result of a violation of this paragraph.

Presentations must give a balanced view of therapeutic options. Use of generic names will contribute to this impartiality. If the CME educational material or content includes trade names, where available trade names from several companies should be used, not just trade names from a single company.

The author must read and agree to the statements above.

Tobacco Related Remuneration:

The author or an immediate family member of the author in the past ten years received trips, travel, gifts, or other in-kind payments not directly related to research activities, research funding or other funding in an entity having an investment, licensing, or other commercial interest in tobacco or tobacco products.

Or

The author or an immediate family member of the author in the past ten years received research funding, honoraria, gifts etc. from an entity funded directly by an entity having an investment, licensing or other commercial interest in tobacco or tobacco products.

The author must read and agree to the statements above.

Step 5, Preview & Submit

Please proofread your submission prior to submitting

Once submitted, you will no longer be able to make edits to the abstract. If you need to make changes prior to the submission deadline, please contact us at wclc2017-abstracts at icsevents.com

Please carefully review the affiliation of all your co-authors as this is how it will appear in the JTO and as well as the IASLC WCLC 2017 Scientific Program

Sponsors Exhibitors
General Info

The IASLC 18th World Conference on Lung Cancer offers a tremendous opportunity to market to one of the largest international gatherings of researchers, clinicians and professionals in the field of lung cancer and thoracic oncology. Over 8,000 clinicians and scientists from around the world are expected to attend. Increase your visibility and organization’s profile by becoming a Sponsor and/or Exhibitor or by holding an Industry Supported Symposium at this outstanding and important Conference.


The Conference is pleased to offer a variety of sponsorship options, including but not limited to:

Industry Supported Symposia

Exhibit Showcase Sessions

Hands-On Training Sessions

Exhibit Space

Signage Opportunities in and around the PACIFICO Yokohama Convention Center

Online and printed advertising opportunities

Scholarship and Travel Grants

Virtual and online conference components

Hotel Key Cards

many more…

Contact

For more information regarding sponsorship, symposium and exhibit opportunities, please contact:

Pia Hirsch

International Association for the Study of Lung Cancer (IASLC)

pia.hirsch at iaslc.org

Phone: +1 720 325 2951

Fax: +1 720 325 2848

Exhibition Housing Info

The IASLC 18th World Conference on Lung Cancer offers a tremendous opportunity to market to one of the largest international gatherings of researchers, clinicians and professionals in the field of lung cancer and thoracic oncology. Over 8,000 clinicians and scientists from around the world are expected to attend. Increase your visibility and organization’s profile by becoming a Sponsor and/or Exhibitor or by holding an Industry Supported Symposium at this outstanding and important Conference. 

 

The Conference is pleased to offer a variety of sponsorship options, including but not limited to:

Exhibit Showcase Sessions

Exhibit Space

Sponsorship of Poster Sessions in Exhibit Hall

Sponsorship of Delegate Lounges in Exhibit Hall

many more…

Confirmed Exhibitors

The IASLC WCLC 2017 would like to thank the following exhibitors for their generous support

Abbvie

Ariad

AstraZeneca

Bayer

Bristol-Myers Squibb

Boehringer Ingelheim

Celgene

Guardant Health

IASLC

Lilly

Median Technologies

Merck

Novartis

Pfizer

Roche

Scanlan

Exhibition Floor plans
Contact
Organising Agency

International Conference Services Ltd. 

1201 West Pender Street, Suite 300

Vancouver, BC, Canada

V6E 2V2

Phone: +1 604 681 2153 Fax: +1 604 681 1049

Official Event Webpage
Event map
Revelant Events